Founded Date: 2019-01-01
Funding Status: Early Stage Venture
Total Funding: 6000000.0
Headquarters: Paris, Ile-de-France, France
Last Funding Date: 2022-09-02
Investors Number: 5.0
Last Funding Type: Series A
Industry: Early Drug Development